Skip to content

The Effect of Ultra-Low Dose of Naloxone Added to Lidocaine-Fentanyl Mixture on Axillary Brachial Plexus Blockade

Phase 2 Study of Assessing the Effect of Ultra-Low-Dose Naloxone on Accentuating the Effect of Fentanyl on Enhancing the Local Anesthetic Characteristic of Lidocaine

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138711211666N1
Enrollment
60
Registered
2009-02-12
Start date
2009-02-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Fracture of distal of radius. Condition 2: Local Anesthesia. Fracture of lower end of radius Local anaesthetics

Interventions

Intervention 1: 34ml 1.5% lidocaine solution containing 100 ng naloxone. Intervention 2: 34ml 1.5% lidocaine alone. Intervention 3: 34ml 1.5%lidocaine solution containing 100 microgram fentanyl. Inter
34ml 1.5% lidocaine solution containing 100 ng naloxone
34ml 1.5% lidocaine alone
34ml 1.5%lidocaine solution containing 100 microgram fentanyl
34ml 1.5% lidocaine solution containing 100 microgram fentanyl & 100 ng naloxone

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Distal Radius Fracture; Exclusion Criteria: Diabetes mellitus, Addiction, Recent analgesic or narcotic medication.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Block Time. Timepoint: every 15 minutes. Method of measurement: Pinprick test.

Secondary

MeasureTime frame
Post operative pain. Timepoint: every 4 hrs. Method of measurement: VAS (visual analog scale).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Movafegh

Anesthesiology Dep, Tehran University of Medical Sciences

movafegh@sina.tums.ac.ir, ali@movafegh.com+98 21 8490 2372

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026